FDA NDC Directory · JSON-LD · Markdown

Desvenlafaxine

NDC 10135-821 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerMarlex Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA204805
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsDESVENLAFAXINE SUCCINATE (50 mg/1)
Marketing started20250701
Package count4

External sources

Source: openFDA. Public-domain (CC0).